Fact CheckerSign in

NCT07526454Completed

Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder

Comparative Efficacy of Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder

Source: ClinicalTrials.gov · Last updated 13 Apr 2026

Brief summary (registry, in English)

This study aimed to compare the efficacy, safety, and tolerability of electroconvulsive therapy (ECT) versus intravenous (IV) ketamine in adults with treatment-resistant major depressive disorder (TRD).

Status (registry)
Completed
Study type
Interventional
Enrollment
70 (actual)
First submitted
6 Apr 2026
Start date
1 Jul 2025
Primary completion date
1 Feb 2026
Lead sponsor
Tanta University
Diseases
Depression
NCT number
NCT07526454

What you commit to

  • Study type: Interventional
  • Participants enrolled: 70
  • From 1 Jul 2025 to the primary completion date, 1 Feb 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of psychotic disorders or bipolar disorder.
  • Current substance use disorder.
  • Significant neurological disorders or traumatic brain injury.
  • cardiovascular diseases in the past six months.

Other

  • Uncontrolled hyper- tension.
  • Pregnancy or breastfeeding.

Who the study is looking for

  • Adults aged 18-75 years.
  • Current diagnosis of major depressive disorder (MDD) according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria.
  • Treatment resistance defined as failure to respond to ≥2 adequate antidepressant trials in the current episode.
  • Montgomery-Åsberg Depression Rating Scale (MADRS) score ≥20.
  • Capacity to provide informed consent.

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tanta university
Coordinator of this site? Confirm its status
TantaEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.